| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.5B | $10.5B | $11.6B | $11.8B | $9.2B | $2.1B | $3.2B | $3.6B |
| Cost of Revenue | $4.4B | $5.0B | $5.5B | $5.4B | $4.4B | $4.7B | $6.8B | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $4.7B | $5.0B | $5.0B | $4.8B | $4.2B | $4.5B | $5.3B | $4.5B |
| Operating Income | $0.3B | $-0.0B | $0.3B | $1.6B | $0.6B | $-0.3B | $0.2B | $0.5B |
| Net Income | $-0.2B | $-1.0B | $0.1B | $1.4B | $0.4B | $-0.5B | $0.1B | $-0.1B |
| EPS (Basic) | $-0.49 | $-2.49 | $0.31 | $3.55 | $1.05 | $-1.24 | $0.33 | $-0.23 |
| EPS (Diluted) | $-0.48 | $-2.49 | $0.31 | $3.53 | $1.04 | $-1.22 | $0.32 | $-0.23 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.4B | $11.6B | $14.0B | $13.3B | $13.8B | $11.1B | $10.4B | $10.0B |
| Current Assets | $3.8B | $4.2B | $5.2B | $4.6B | $4.8B | $5.0B | $4.7B | $4.4B |
| Cash & Equivalents | $0.4B | $0.7B | $0.8B | $1.3B | $0.8B | $1.4B | $0.5B | $0.6B |
| Total Liabilities | $7.9B | $10.0B | $11.1B | $9.8B | $10.7B | $7.8B | $6.1B | $6.2B |
| Current Liabilities | $2.7B | $3.5B | $3.5B | $3.3B | $2.2B | $3.0B | $2.7B | $2.7B |
| Stockholders' Equity | $1.5B | $1.7B | $2.9B | $3.5B | $3.1B | $3.4B | $4.3B | $3.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $1.0B | $-0.7B | $0.9B | $1.3B | $0.9B | $1.7B | $1.5B |
| Investing Cash Flow | $1.4B | $-0.2B | $-0.2B | $0.9B | $-2.9B | $-0.3B | $-0.2B | $-0.8B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-2.1B | $-1.0B | $0.5B | $-1.3B | $1.1B | $0.3B | $-1.6B | $-1.4B |